Systemic Immune-Inflammation Index and Mortality in Testicular Cancer: A Systematic Review and Meta-Analysis
Diagnostics · 22.02.2023 · 13 (5) · 843
DOI: 10.3390/diagnostics13050843 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 22.02.2023. Verfasst von Farley E Salazar-Valdivia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Medicina, Universidad Peruana de Ciencias Aplicadas, Lima 15023, Peru. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The systemic immune-inflammation index (SIII) is a marker studied in multiple types of urologic cancer. This systematic review evaluates the association between SIII values with overall survival (OS) and progression-free survival (PFS) in testicular cancer. We searched observational studies in five databases. The quantitative synthesis was performed using a random-effects model. The risk of bias was assessed using the Newcastle–Ottawa Scale (NOS). The only measure of the effect was the hazard ratio (HR). A sensitivity analysis was performed according to the risk of bias in the studies. There were 833 participants in a total of 6 cohorts. We found that high SIII values were associated with worse OS (HR = 3.28; 95% CI 1.3–8.9; p < 0.001; I2 = 78) and PFS (HR = 3.9; 95% CI 2.53–6.02; p < 0.001; I2 = 0). No indication of small study effects was found in the association between SIII values and OS (p = 0.5301). High SIII values were associated with worse OS and PFS. However, further primary studies are suggested to enhance the effect of this marker in different outcomes of testicular cancer patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Escuela de Medicina, Universidad Peruana de Ciencias Aplicadas, Lima 15023, Peru.
- Sociedad Científica de Estudiantes de Medicina de la Universidad Peruana de Ciencias Aplicadas, Lima 15023, Peru.
- Sociedad Científica de Estudiantes de Medicina de la Universidad Nacional de Trujillo, Trujillo 13011, Peru.
- Grupo Peruano de Investigación Epidemiológica, Unidad para la Generación y Síntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima 15012, Peru.
- Escuela de Medicina, Universidad Privada San Juan Bautista, Lima 15067, Peru.
- Universidad Privada del Norte, Trujillo 13011, Peru.
ORCID-Profile: Juan R Ulloque-Badaracco, Enrique A Hernandez-Bustamante, Percy Herrera-Añazco, Adrian V Hernandez
Zitieren
APA
Salazar-Valdivia, F. E., Valdez-Cornejo, V. A., Ulloque-Badaracco, J. R., Hernandez-Bustamante, E. A., Alarcón-Braga, E. A., Mosquera-Rojas, M. D., Garrido-Matta, D. P., Herrera-Añazco, P., Benites-Zapata, V. A., & Hernandez, A. V. (2023). Systemic Immune-Inflammation Index and Mortality in Testicular Cancer: A Systematic Review and Meta-Analysis. Diagnostics, 13(5), 843. https://doi.org/10.3390/diagnostics13050843
Vancouver
Salazar-Valdivia FE, Valdez-Cornejo VA, Ulloque-Badaracco JR, Hernandez-Bustamante EA, Alarcón-Braga EA, Mosquera-Rojas MD, et al. Systemic Immune-Inflammation Index and Mortality in Testicular Cancer: A Systematic Review and Meta-Analysis. Diagnostics. 2023;13(5):843. doi:10.3390/diagnostics13050843
BibTeX
@article{SalazarValdivia2023,
author = {Salazar-Valdivia, Farley E and Valdez-Cornejo, Valeria A and Ulloque-Badaracco, Juan R and Hernandez-Bustamante, Enrique A and Alarcón-Braga, Esteban A and Mosquera-Rojas, Melany D and Garrido-Matta, Diana P and Herrera-Añazco, Percy and Benites-Zapata, Vicente A and Hernandez, Adrian V},
title = {Systemic Immune-Inflammation Index and Mortality in Testicular Cancer: A Systematic Review and Meta-Analysis},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {5},
pages = {843},
doi = {10.3390/diagnostics13050843}
}
EUVIMED